Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mF1v2jAUhu/5FVHuSYCxkk2BamPthtRqjII27aYyyaGYmTg9tvn69XMI3ejkrK2pL2M77znxef34KPH5Zsm8FaCgPOv6zaDhe5AlPKXZXdefjC/rkX/eq8ULsiJHyzpBI2i2fC9hRIiuX8wGUyCZCH5cX30C/T6g36t5MZ8uIJGP1ilJWfCFiPk1yYs1XrziNPWWIOc87fq5kvtRLxYSdRa9NcdfIicJxOFh5Hh2cds+Ho/DQuwZqkoAXpHszig6QyvNRCFCJvtEwh3HrVk6uW1FnbNGI7IKQcUIBFeYwJDI+RD5iqaQmiMRJsAqyGyd3gCuGMgiiFE8XCRLYSVOFmQzgvuBOekPerYvN7LeqDc7UbPdiJqdVrttV2M82iqzefRHhLog787eRmetcIahhERXEOl9XRdxxxndqSWZWpZqyFES5qhIVPQf281RHIT7J82QUpEzsg0WIrfdKoJETwNqKLj7kOILxqgxxfSe/aOfKcbCF2Y9OUDEUcYFo/pcaT+aWXI5st2IPs8kbKoraoc/uTl4kYJ4Pdkdz8zoH6opo4kt4TSDFAg5GQ2qAeeQDR+JgAm6g8N3mqV8LV4fOsdFdpR9vufmf67PdhRF1ifqp/ZTxe1zoZDnEGoYUXEKYwbZjJ9KF21Rs9SDQV15c98Z8YQwqOiN6pbc0aZ8aOWc2d7dkSonjKKfL8a2bvmmALc3+0ejNE27f+psB2UXpNferEz85U4vj/szuuZ29MZuExSaaTKXMhfvw3C9XgdzIuqC6M0K9HFyDP+j69ddC+/kji97nhKhjlKfljfjywpme/6e6gJO7WwP7x86aGMMiQpOqEWJamdAHVy8PqP/trXO0h4+Yoq7MPsWlEjKM1e9kJoaFU+7FXRds0vUgPg6m9GKPyuVvozD8q9OrxaHxR+dXu03CVYAOg==
0MpDNXRgmw26WjfF
